Popular Articles

Smokeless Tobacco Safer Than Smoking
Smokeless tobacco products, as used in Europe and North America, do not appear to increase cancer risk. A large meta-analysis, published in the open access journal BMC Medicine, has shown that snuff as used in Scandinavia has no discernible effect on the risk of various cancers. Products used in the past in the USA may have increased the risk, but any effect that exists now seems likely to be quite small.
generic viagra online
Senate Dems Eye August Timeline, Search For Savings
Despite some roadblocks, Senate Democrats are trying to hold true to their pledge to pass health care reform legislation by the August recess, Roll Call reports.
News of the day
House Ways And Means Panel Rejects Amendments To Exclude Abortion Coverage From Health Reform
The House Ways and Means Committee on Thursday voted 23-18 to approve its health care reform bill (HR 3200) after rejecting dozens of Republican amendments, including attempts to exclude abortion coverage from the essential benefit package created in the legislation, CQ Today reports. An amendment offered by Rep. Sam Johnson (R-Texas) was rejected in an 18-23 vote; Reps. Bill Pascrell (N.J.), Earl Pomeroy (N.D.) and John Tanner (Tenn.) were the only Democrats to support the amendment. The amendment included exceptions for abortion to save the woman"s life or in cases of rape or incest. Committee members voted 19-22 to reject a similar amendment by House Minority Whip Eric Cantor (R-Va.).The House health reform bill would establish a panel to set a minimum benefits package that health insurers must offer. The bill aims to expand health insurance coverage by mandating that individuals obtain insurance, requiring employers to offer workers coverage or pay a fine, and establishing a health insurance exchange where people could compare and purchase plans. The exchange would include a government-run health insurance option that would compete with private plans (Rubin, CQ Today, 7/17).
Medical Devices

Science Magazine Spotlights 20 Years Of CF Research

An article in Science magazine this month highlights several promising new CF therapies, including VX-770 and VX-809 developed by Vertex Pharmaceuticals, as part of a look back at key moments in CF research since the discovery of the CF gene 20 years ago. The article notes the CF Foundation"s role in scientific discoveries: "The CF Foundation had been instrumental in funding the gene hunt and subsequent CF research, raising and investing tens of millions of dollars." In the piece, Francis Collins, former director of the National Human Genome Research Institute and co-discoverer of the CF gene, says the research community was initially skeptical about the Foundation"s focus on funding drug research to find a cure: "A lot of people thought that [CFF president] Bob Beall was going far out on a limb to put a lot of money into a strategy that was clearly risky." But now, following the Foundation"s investment of more than $75 million to develop VX-770 and VX-809, the "ò€¦two Vertex drugs are taking the CF world by storm." Cystic Fibrosis Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):